<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.jcp.sagepub.com/">
<title>Most-Cited Full-Text Articles</title>
<link>http://www.jcp.sagepub.com/</link>
<description>Most-Cited Full-Text Articles</description>
<prism:coverDisplayDate>2008-08-02</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/40/10/1109?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/24/4/129?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/41/11/1149?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/39/4/327?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/38/11/981?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/40/2/124?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/36/1/55?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/38/2/106?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/36/9/783?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/36/4/315?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/38/7/583?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/41/5/492?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/31/10/1024?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/28/7/609?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/31/7/588?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/43/5/443?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/35/3/209?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/39/12/1203?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/42/11/1228?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/38/3/268?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/38/2/112?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/42/3/297?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/36/1/42?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/35/12/1181?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/43/4/406?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/15/2/139?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/41/1/85?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/21/8_suppl/143S?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/37/11/991?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/44/8/881?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/37/6/486?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/37/2/116?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/34/11/1126?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/41/6/645?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/43/10/1116?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/42/4/395?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/37/5/405?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/35/4/368?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/35/3/302?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/41/8/870?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/39/6/567?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/40/6/624?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/32/7/630?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/40/1/91?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/44/8/854?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/44/4/397?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/44/1/20?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/43/6/565?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/37/1_suppl/40S?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/34/11/1043?rss=1&amp;ssource=mfc" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/40/10/1109?rss=1&amp;ssource=mfc">
<title><![CDATA[Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/40/10/1109?rss=1&amp;ssource=mfc</link>
<description><![CDATA[A Van Hecken, JI Schwartz, M Depre, I De Lepeleire, A Dallob, W Tanaka, K Wynants, A Buntinx, J Arnout, PH Wong, DL Ebel, BJ Gertz, PJ De Schepper<br />Oct  1, 2000; 40:1109-1120<br />Articles]]></description>
<dc:creator>A Van Hecken, JI Schwartz, M Depre, I De Lepeleire, A Dallob, W Tanaka, K Wynants, A Buntinx, J Arnout, PH Wong, DL Ebel, BJ Gertz, PJ De Schepper</dc:creator>
<dc:date>2000-10-01</dc:date>
<dc:title><![CDATA[Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/24/4/129?rss=1&amp;ssource=mfc">
<title><![CDATA[A classification of antiarrhythmic actions reassessed after a decade of new drugs]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/24/4/129?rss=1&amp;ssource=mfc</link>
<description><![CDATA[EM Vaughan Williams<br />Apr  1, 1984; 24:129-147<br />Articles]]></description>
<dc:creator>EM Vaughan Williams</dc:creator>
<dc:date>1984-04-01</dc:date>
<dc:title><![CDATA[A classification of antiarrhythmic actions reassessed after a decade of new drugs]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/41/11/1149?rss=1&amp;ssource=mfc">
<title><![CDATA[Human drug metabolism and the cytochromes P450: application and relevance of in vitro models]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/41/11/1149?rss=1&amp;ssource=mfc</link>
<description><![CDATA[K Venkatakrishnan, LL Von Moltke, DJ Greenblatt<br />Nov  1, 2001; 41:1149-1179<br />Articles]]></description>
<dc:creator>K Venkatakrishnan, LL Von Moltke, DJ Greenblatt</dc:creator>
<dc:date>2001-11-01</dc:date>
<dc:title><![CDATA[Human drug metabolism and the cytochromes P450: application and relevance of in vitro models]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/39/4/327?rss=1&amp;ssource=mfc">
<title><![CDATA[DHEA and DHEA-S: a review]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/39/4/327?rss=1&amp;ssource=mfc</link>
<description><![CDATA[PD Kroboth, FS Salek, AL Pittenger, TJ Fabian, RF Frye<br />Apr  1, 1999; 39:327-348<br />Articles]]></description>
<dc:creator>PD Kroboth, FS Salek, AL Pittenger, TJ Fabian, RF Frye</dc:creator>
<dc:date>1999-04-01</dc:date>
<dc:title><![CDATA[DHEA and DHEA-S: a review]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/38/11/981?rss=1&amp;ssource=mfc">
<title><![CDATA[Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/38/11/981?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jang-Ik Lee, Gilbert J. Burckart<br />Nov  1, 1998; 38:981-993<br />Journal Article]]></description>
<dc:creator>Jang-Ik Lee, Gilbert J. Burckart</dc:creator>
<dc:date>1998-11-01</dc:date>
<dc:identifier>10.1177/009127009803801101</dc:identifier>
<dc:title><![CDATA[Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/40/2/124?rss=1&amp;ssource=mfc">
<title><![CDATA[Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/40/2/124?rss=1&amp;ssource=mfc</link>
<description><![CDATA[PT Leese, RC Hubbard, A Karim, PC Isakson, SS Yu, GS Geis<br />Feb  1, 2000; 40:124-132<br />Articles]]></description>
<dc:creator>PT Leese, RC Hubbard, A Karim, PC Isakson, SS Yu, GS Geis</dc:creator>
<dc:date>2000-02-01</dc:date>
<dc:title><![CDATA[Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/36/1/55?rss=1&amp;ssource=mfc">
<title><![CDATA[Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/36/1/55?rss=1&amp;ssource=mfc</link>
<description><![CDATA[DW Northfelt, FJ Martin, P Working, PA Volberding, J Russell, M Newman, MA Amantea, LD Kaplan<br />Jan  1, 1996; 36:55-63<br />Articles]]></description>
<dc:creator>DW Northfelt, FJ Martin, P Working, PA Volberding, J Russell, M Newman, MA Amantea, LD Kaplan</dc:creator>
<dc:date>1996-01-01</dc:date>
<dc:title><![CDATA[Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/38/2/106?rss=1&amp;ssource=mfc">
<title><![CDATA[Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/38/2/106?rss=1&amp;ssource=mfc</link>
<description><![CDATA[LL von Moltke, DJ Greenblatt, JM Grassi, BW Granda, SX Duan, SM Fogelman, JP Daily, JS Harmatz, RI Shader<br />Feb  1, 1998; 38:106-111<br />Articles]]></description>
<dc:creator>LL von Moltke, DJ Greenblatt, JM Grassi, BW Granda, SX Duan, SM Fogelman, JP Daily, JS Harmatz, RI Shader</dc:creator>
<dc:date>1998-02-01</dc:date>
<dc:title><![CDATA[Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/36/9/783?rss=1&amp;ssource=mfc">
<title><![CDATA[Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/36/9/783?rss=1&amp;ssource=mfc</link>
<description><![CDATA[LL von Moltke, DJ Greenblatt, J Schmider, SX Duan, CE Wright, JS Harmatz, RI Shader<br />Sep  1, 1996; 36:783-791<br />Articles]]></description>
<dc:creator>LL von Moltke, DJ Greenblatt, J Schmider, SX Duan, CE Wright, JS Harmatz, RI Shader</dc:creator>
<dc:date>1996-09-01</dc:date>
<dc:title><![CDATA[Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/36/4/315?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/36/4/315?rss=1&amp;ssource=mfc</link>
<description><![CDATA[R Bullingham, S Monroe, A Nicholls, M Hale<br />Apr  1, 1996; 36:315-324<br />Articles]]></description>
<dc:creator>R Bullingham, S Monroe, A Nicholls, M Hale</dc:creator>
<dc:date>1996-04-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/38/7/583?rss=1&amp;ssource=mfc">
<title><![CDATA[AmBisome (liposomal amphotericin B): a comparative review]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/38/7/583?rss=1&amp;ssource=mfc</link>
<description><![CDATA[GW Boswell, D Buell, I Bekersky<br />Jul  1, 1998; 38:583-592<br />Articles]]></description>
<dc:creator>GW Boswell, D Buell, I Bekersky</dc:creator>
<dc:date>1998-07-01</dc:date>
<dc:title><![CDATA[AmBisome (liposomal amphotericin B): a comparative review]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/41/5/492?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics and bioavailability of quercetin glycosides in humans]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/41/5/492?rss=1&amp;ssource=mfc</link>
<description><![CDATA[EU Graefe, J Wittig, S Mueller, AK Riethling, B Uehleke, B Drewelow, H Pforte, G Jacobasch, H Derendorf, M Veit<br />May  1, 2001; 41:492-499<br />Articles]]></description>
<dc:creator>EU Graefe, J Wittig, S Mueller, AK Riethling, B Uehleke, B Drewelow, H Pforte, G Jacobasch, H Derendorf, M Veit</dc:creator>
<dc:date>2001-05-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics and bioavailability of quercetin glycosides in humans]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/31/10/1024?rss=1&amp;ssource=mfc">
<title><![CDATA[Echocardiographic evaluation of the cardiovascular effects of short-duration spaceflight]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/31/10/1024?rss=1&amp;ssource=mfc</link>
<description><![CDATA[SL Mulvagh, JB Charles, JM Riddle, TL Rehbein, MW Bungo<br />Oct  1, 1991; 31:1024-1026<br />Articles]]></description>
<dc:creator>SL Mulvagh, JB Charles, JM Riddle, TL Rehbein, MW Bungo</dc:creator>
<dc:date>1991-10-01</dc:date>
<dc:title><![CDATA[Echocardiographic evaluation of the cardiovascular effects of short-duration spaceflight]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/28/7/609?rss=1&amp;ssource=mfc">
<title><![CDATA[The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/28/7/609?rss=1&amp;ssource=mfc</link>
<description><![CDATA[AM Frydman, L Bara, Y Le Roux, M Woler, F Chauliac, MM Samama<br />Jul  1, 1988; 28:609-618<br />Articles]]></description>
<dc:creator>AM Frydman, L Bara, Y Le Roux, M Woler, F Chauliac, MM Samama</dc:creator>
<dc:date>1988-07-01</dc:date>
<dc:title><![CDATA[The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/31/7/588?rss=1&amp;ssource=mfc">
<title><![CDATA[Nonsteroidal anti-inflammatory drugs: effects on kidney function]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/31/7/588?rss=1&amp;ssource=mfc</link>
<description><![CDATA[A Whelton, CW Hamilton<br />Jul  1, 1991; 31:588-598<br />Articles]]></description>
<dc:creator>A Whelton, CW Hamilton</dc:creator>
<dc:date>1991-07-01</dc:date>
<dc:title><![CDATA[Nonsteroidal anti-inflammatory drugs: effects on kidney function]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/43/5/443?rss=1&amp;ssource=mfc">
<title><![CDATA[The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/43/5/443?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, Scott R. Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh, Steven A. Wrighton<br />May  1, 2003; 43:443-469<br />Drug Development]]></description>
<dc:creator>Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, Scott R. Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh, Steven A. Wrighton</dc:creator>
<dc:date>2003-05-01</dc:date>
<dc:identifier>10.1177/0091270003252519</dc:identifier>
<dc:title><![CDATA[The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/35/3/209?rss=1&amp;ssource=mfc">
<title><![CDATA[Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/35/3/209?rss=1&amp;ssource=mfc</link>
<description><![CDATA[AI Schafer<br />Mar  1, 1995; 35:209-219<br />Articles]]></description>
<dc:creator>AI Schafer</dc:creator>
<dc:date>1995-03-01</dc:date>
<dc:title><![CDATA[Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/39/12/1203?rss=1&amp;ssource=mfc">
<title><![CDATA[The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/39/12/1203?rss=1&amp;ssource=mfc</link>
<description><![CDATA[DK Yu<br />Dec  1, 1999; 39:1203-1211<br />Articles]]></description>
<dc:creator>DK Yu</dc:creator>
<dc:date>1999-12-01</dc:date>
<dc:title><![CDATA[The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/42/11/1228?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/42/11/1228?rss=1&amp;ssource=mfc</link>
<description><![CDATA[T Chen, J Berenson, R Vescio, R Swift, A Gilchick, S Goodin, P LoRusso, P Ma, C Ravera, F Deckert, H Schran, J Seaman, A Skerjanec<br />Nov  1, 2002; 42:1228-1236<br />Articles]]></description>
<dc:creator>T Chen, J Berenson, R Vescio, R Swift, A Gilchick, S Goodin, P LoRusso, P Ma, C Ravera, F Deckert, H Schran, J Seaman, A Skerjanec</dc:creator>
<dc:date>2002-11-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/38/3/268?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/38/3/268?rss=1&amp;ssource=mfc</link>
<description><![CDATA[LM Shaw, R Mick, I Nowak, M Korecka, KL Brayman<br />Mar  1, 1998; 38:268-275<br />Articles]]></description>
<dc:creator>LM Shaw, R Mick, I Nowak, M Korecka, KL Brayman</dc:creator>
<dc:date>1998-03-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/38/2/112?rss=1&amp;ssource=mfc">
<title><![CDATA[Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/38/2/112?rss=1&amp;ssource=mfc</link>
<description><![CDATA[K Venkatakrishnan, DJ Greenblatt, LL von Moltke, J Schmider, JS Harmatz, RI Shader<br />Feb  1, 1998; 38:112-121<br />Articles]]></description>
<dc:creator>K Venkatakrishnan, DJ Greenblatt, LL von Moltke, J Schmider, JS Harmatz, RI Shader</dc:creator>
<dc:date>1998-02-01</dc:date>
<dc:title><![CDATA[Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/42/3/297?rss=1&amp;ssource=mfc">
<title><![CDATA[The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/42/3/297?rss=1&amp;ssource=mfc</link>
<description><![CDATA[W Timmer, V Leclerc, G Birraux, M Neuhauser, A Hatzelmann, T Bethke, W Wurst<br />Mar  1, 2002; 42:297-303<br />Articles]]></description>
<dc:creator>W Timmer, V Leclerc, G Birraux, M Neuhauser, A Hatzelmann, T Bethke, W Wurst</dc:creator>
<dc:date>2002-03-01</dc:date>
<dc:title><![CDATA[The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/36/1/42?rss=1&amp;ssource=mfc">
<title><![CDATA[Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/36/1/42?rss=1&amp;ssource=mfc</link>
<description><![CDATA[A Taddio, S Ito, G Koren<br />Jan  1, 1996; 36:42-47<br />Articles]]></description>
<dc:creator>A Taddio, S Ito, G Koren</dc:creator>
<dc:date>1996-01-01</dc:date>
<dc:title><![CDATA[Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/35/12/1181?rss=1&amp;ssource=mfc">
<title><![CDATA[Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/35/12/1181?rss=1&amp;ssource=mfc</link>
<description><![CDATA[IH Benedek, AS Joshi, HJ Pieniaszek, SY King, DM Kornhauser<br />Dec  1, 1995; 35:1181-1186<br />Articles]]></description>
<dc:creator>IH Benedek, AS Joshi, HJ Pieniaszek, SY King, DM Kornhauser</dc:creator>
<dc:date>1995-12-01</dc:date>
<dc:title><![CDATA[Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/43/4/406?rss=1&amp;ssource=mfc">
<title><![CDATA[Single-Dose Pharmacokinetics and Pharmacodynamics of RWJ 67657, a Specific p38 Mitogen-Activated Protein Kinase Inhibitor: A First-in-Human Study]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/43/4/406?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Dolly A. Parasrampuria, Peter de Boer, Daksha Desai-Krieger, Andrew T. Chow, C. Richard Jones<br />Apr  1, 2003; 43:406-413<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Dolly A. Parasrampuria, Peter de Boer, Daksha Desai-Krieger, Andrew T. Chow, C. Richard Jones</dc:creator>
<dc:date>2003-04-01</dc:date>
<dc:identifier>10.1177/0091270002250615</dc:identifier>
<dc:title><![CDATA[Single-Dose Pharmacokinetics and Pharmacodynamics of RWJ 67657, a Specific p38 Mitogen-Activated Protein Kinase Inhibitor: A First-in-Human Study]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/15/2/139?rss=1&amp;ssource=mfc">
<title><![CDATA[Analgesic Effect of Delta-9-Tetrahydrocannabinol]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/15/2/139?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Russell Noyes JR., S. Fred Brunk, David A. Baram, Arthur Canter<br />Feb  1, 1975; 15:139-143<br />Human Pharmacology]]></description>
<dc:creator>Russell Noyes JR., S. Fred Brunk, David A. Baram, Arthur Canter</dc:creator>
<dc:date>1975-02-01</dc:date>
<dc:title><![CDATA[Analgesic Effect of Delta-9-Tetrahydrocannabinol]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/41/1/85?rss=1&amp;ssource=mfc">
<title><![CDATA[Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/41/1/85?rss=1&amp;ssource=mfc</link>
<description><![CDATA[LL von Moltke, DJ Greenblatt, BW Granda, GM Giancarlo, SX Duan, JP Daily, JS Harmatz, RI Shader<br />Jan  1, 2001; 41:85-91<br />Articles]]></description>
<dc:creator>LL von Moltke, DJ Greenblatt, BW Granda, GM Giancarlo, SX Duan, JP Daily, JS Harmatz, RI Shader</dc:creator>
<dc:date>2001-01-01</dc:date>
<dc:title><![CDATA[Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/21/8_suppl/143S?rss=1&amp;ssource=mfc">
<title><![CDATA[Clinical relevance of cannabis tolerance and dependence]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/21/8_suppl/143S?rss=1&amp;ssource=mfc</link>
<description><![CDATA[RT Jones, NL Benowitz, RI Herning<br />Aug  1, 1981; 21:143-152<br />Articles]]></description>
<dc:creator>RT Jones, NL Benowitz, RI Herning</dc:creator>
<dc:date>1981-08-01</dc:date>
<dc:title><![CDATA[Clinical relevance of cannabis tolerance and dependence]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/37/11/991?rss=1&amp;ssource=mfc">
<title><![CDATA[Matrix metalloproteinases and coronary artery disease: a novel therapeutic target]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/37/11/991?rss=1&amp;ssource=mfc</link>
<description><![CDATA[DC Celentano, WH Frishman<br />Nov  1, 1997; 37:991-1000<br />Articles]]></description>
<dc:creator>DC Celentano, WH Frishman</dc:creator>
<dc:date>1997-11-01</dc:date>
<dc:title><![CDATA[Matrix metalloproteinases and coronary artery disease: a novel therapeutic target]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/44/8/881?rss=1&amp;ssource=mfc">
<title><![CDATA[Effects of Nicotine on the Number and Activity of Circulating Endothelial Progenitor Cells]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/44/8/881?rss=1&amp;ssource=mfc</link>
<description><![CDATA[XingXiang Wang, JunHui Zhu, JunZhu Chen, YunPeng Shang<br />Aug  1, 2004; 44:881-889<br />Clinical Studies]]></description>
<dc:creator>XingXiang Wang, JunHui Zhu, JunZhu Chen, YunPeng Shang</dc:creator>
<dc:date>2004-08-01</dc:date>
<dc:identifier>10.1177/0091270004267593</dc:identifier>
<dc:title><![CDATA[Effects of Nicotine on the Number and Activity of Circulating Endothelial Progenitor Cells]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/37/6/486?rss=1&amp;ssource=mfc">
<title><![CDATA[Stability and performance of a population pharmacokinetic model]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/37/6/486?rss=1&amp;ssource=mfc</link>
<description><![CDATA[EI Ette<br />Jun  1, 1997; 37:486-495<br />Articles]]></description>
<dc:creator>EI Ette</dc:creator>
<dc:date>1997-06-01</dc:date>
<dc:title><![CDATA[Stability and performance of a population pharmacokinetic model]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/37/2/116?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/37/2/116?rss=1&amp;ssource=mfc</link>
<description><![CDATA[LM White, SF Gardner, BJ Gurley, MA Marx, PL Wang, M Estes<br />Feb  1, 1997; 37:116-122<br />Articles]]></description>
<dc:creator>LM White, SF Gardner, BJ Gurley, MA Marx, PL Wang, M Estes</dc:creator>
<dc:date>1997-02-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/34/11/1126?rss=1&amp;ssource=mfc">
<title><![CDATA[Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/34/11/1126?rss=1&amp;ssource=mfc</link>
<description><![CDATA[PA Reece, AJ Sedman, S Rose, DS Wright, R Dawkins, R Rajagopalan<br />Nov  1, 1994; 34:1126-1132<br />Articles]]></description>
<dc:creator>PA Reece, AJ Sedman, S Rose, DS Wright, R Dawkins, R Rajagopalan</dc:creator>
<dc:date>1994-11-01</dc:date>
<dc:title><![CDATA[Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/41/6/645?rss=1&amp;ssource=mfc">
<title><![CDATA[The pharmacokinetics of colistin in patients with cystic fibrosis]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/41/6/645?rss=1&amp;ssource=mfc</link>
<description><![CDATA[MD Reed, RC Stern, MA O''Riordan, JL Blumer<br />Jun  1, 2001; 41:645-654<br />Articles]]></description>
<dc:creator>MD Reed, RC Stern, MA O''Riordan, JL Blumer</dc:creator>
<dc:date>2001-06-01</dc:date>
<dc:title><![CDATA[The pharmacokinetics of colistin in patients with cystic fibrosis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/43/10/1116?rss=1&amp;ssource=mfc">
<title><![CDATA[Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/43/10/1116?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Joseph L. Kuti, Prachi K. Dandekar, Charles H. Nightingale, David P. Nicolau<br />Oct  1, 2003; 43:1116-1123<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Joseph L. Kuti, Prachi K. Dandekar, Charles H. Nightingale, David P. Nicolau</dc:creator>
<dc:date>2003-10-01</dc:date>
<dc:identifier>10.1177/0091270003257225</dc:identifier>
<dc:title><![CDATA[Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/42/4/395?rss=1&amp;ssource=mfc">
<title><![CDATA[Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/42/4/395?rss=1&amp;ssource=mfc</link>
<description><![CDATA[HM Lazarus, JL Blumer, S Yanovich, H Schlamm, A Romero<br />Apr  1, 2002; 42:395-402<br />Articles]]></description>
<dc:creator>HM Lazarus, JL Blumer, S Yanovich, H Schlamm, A Romero</dc:creator>
<dc:date>2002-04-01</dc:date>
<dc:title><![CDATA[Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/37/5/405?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/37/5/405?rss=1&amp;ssource=mfc</link>
<description><![CDATA[JJ Zimmerman, BD Kahan<br />May  1, 1997; 37:405-415<br />Articles]]></description>
<dc:creator>JJ Zimmerman, BD Kahan</dc:creator>
<dc:date>1997-05-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/35/4/368?rss=1&amp;ssource=mfc">
<title><![CDATA[Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/35/4/368?rss=1&amp;ssource=mfc</link>
<description><![CDATA[SC Piscitelli, A Thibault, WD Figg, A Tompkins, D Headlee, R Lieberman, D Samid, CE Myers<br />Apr  1, 1995; 35:368-373<br />Articles]]></description>
<dc:creator>SC Piscitelli, A Thibault, WD Figg, A Tompkins, D Headlee, R Lieberman, D Samid, CE Myers</dc:creator>
<dc:date>1995-04-01</dc:date>
<dc:title><![CDATA[Disposition of phenylbutyrate and its metabolites, phenylacetate and phenylacetylglutamine]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/35/3/302?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/35/3/302?rss=1&amp;ssource=mfc</link>
<description><![CDATA[H Derendorf, G Hochhaus, S Rohatagi, H Mollmann, J Barth, H Sourgens, M Erdmann<br />Mar  1, 1995; 35:302-305<br />Articles]]></description>
<dc:creator>H Derendorf, G Hochhaus, S Rohatagi, H Mollmann, J Barth, H Sourgens, M Erdmann</dc:creator>
<dc:date>1995-03-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics of triamcinolone acetonide after intravenous, oral, and inhaled administration]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/41/8/870?rss=1&amp;ssource=mfc">
<title><![CDATA[Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/41/8/870?rss=1&amp;ssource=mfc</link>
<description><![CDATA[JD Iuliucci, SD Oliver, S Morley, C Ward, J Ward, D Dalgarno, T Clackson, HJ Berger<br />Aug  1, 2001; 41:870-879<br />Articles]]></description>
<dc:creator>JD Iuliucci, SD Oliver, S Morley, C Ward, J Ward, D Dalgarno, T Clackson, HJ Berger</dc:creator>
<dc:date>2001-08-01</dc:date>
<dc:title><![CDATA[Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/39/6/567?rss=1&amp;ssource=mfc">
<title><![CDATA[Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/39/6/567?rss=1&amp;ssource=mfc</link>
<description><![CDATA[K Venkatakrishnan, LL von Moltke, DJ Greenblatt<br />Jun  1, 1999; 39:567-577<br />Articles]]></description>
<dc:creator>K Venkatakrishnan, LL von Moltke, DJ Greenblatt</dc:creator>
<dc:date>1999-06-01</dc:date>
<dc:title><![CDATA[Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/40/6/624?rss=1&amp;ssource=mfc">
<title><![CDATA[Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/40/6/624?rss=1&amp;ssource=mfc</link>
<description><![CDATA[LM Shaw, M Korecka, S Aradhye, R Grossman, L Bayer, C Innes, A Cucciara, C Barker, A Naji, A Nicholls, K Brayman<br />Jun  1, 2000; 40:624-633<br />Articles]]></description>
<dc:creator>LM Shaw, M Korecka, S Aradhye, R Grossman, L Bayer, C Innes, A Cucciara, C Barker, A Naji, A Nicholls, K Brayman</dc:creator>
<dc:date>2000-06-01</dc:date>
<dc:title><![CDATA[Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/32/7/630?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/32/7/630?rss=1&amp;ssource=mfc</link>
<description><![CDATA[FL Tse, JM Jaffe, A Troendle<br />Jul  1, 1992; 32:630-638<br />Articles]]></description>
<dc:creator>FL Tse, JM Jaffe, A Troendle</dc:creator>
<dc:date>1992-07-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/40/1/91?rss=1&amp;ssource=mfc">
<title><![CDATA[Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/40/1/91?rss=1&amp;ssource=mfc</link>
<description><![CDATA[RA Boyd, RH Stern, BH Stewart, X Wu, EL Reyner, EA Zegarac, EJ Randinitis, L Whitfield<br />Jan  1, 2000; 40:91-98<br />Articles]]></description>
<dc:creator>RA Boyd, RH Stern, BH Stewart, X Wu, EL Reyner, EA Zegarac, EJ Randinitis, L Whitfield</dc:creator>
<dc:date>2000-01-01</dc:date>
<dc:title><![CDATA[Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/44/8/854?rss=1&amp;ssource=mfc">
<title><![CDATA[Influence of Genetic Variants in UGT1A1 and UGT1A9 on the In Vivo Glucuronidation of SN-38]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/44/8/854?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Luca Paoluzzi, Arun S. Singh, Douglas K. Price, Romano Danesi, Ron H. J. Mathijssen, Jaap Verweij, William D. Figg, Alex Sparreboom<br />Aug  1, 2004; 44:854-860<br />Pharmacogenetics]]></description>
<dc:creator>Luca Paoluzzi, Arun S. Singh, Douglas K. Price, Romano Danesi, Ron H. J. Mathijssen, Jaap Verweij, William D. Figg, Alex Sparreboom</dc:creator>
<dc:date>2004-08-01</dc:date>
<dc:identifier>10.1177/0091270004267159</dc:identifier>
<dc:title><![CDATA[Influence of Genetic Variants in UGT1A1 and UGT1A9 on the In Vivo Glucuronidation of SN-38]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/44/4/397?rss=1&amp;ssource=mfc">
<title><![CDATA[Epidemiology of Diabetes]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/44/4/397?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Nathaniel Winer, James R. Sowers<br />Apr  1, 2004; 44:397-405<br />Symposium]]></description>
<dc:creator>Nathaniel Winer, James R. Sowers</dc:creator>
<dc:date>2004-04-01</dc:date>
<dc:identifier>10.1177/0091270004263017</dc:identifier>
<dc:title><![CDATA[Epidemiology of Diabetes]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/44/1/20?rss=1&amp;ssource=mfc">
<title><![CDATA[Global Burden of Disease (GBD) for Hepatitis C]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/44/1/20?rss=1&amp;ssource=mfc</link>
<description><![CDATA[  The Global Burden of Hepatitis C Working Group<br />Jan  1, 2004; 44:20-29<br />Methods]]></description>
<dc:creator>  The Global Burden of Hepatitis C Working Group</dc:creator>
<dc:date>2004-01-01</dc:date>
<dc:identifier>10.1177/0091270003258669</dc:identifier>
<dc:title><![CDATA[Global Burden of Disease (GBD) for Hepatitis C]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/43/6/565?rss=1&amp;ssource=mfc">
<title><![CDATA[Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron-Chelating Agent in Patients with Transfusion-Dependent Iron Overload Due to {beta}-Thalassemia]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/43/6/565?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Renzo Galanello, Antonio Piga, Daniele Alberti, Marie-Claude Rouan, Hilde Bigler, Romain Sechaud<br />Jun  1, 2003; 43:565-572<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Renzo Galanello, Antonio Piga, Daniele Alberti, Marie-Claude Rouan, Hilde Bigler, Romain Sechaud</dc:creator>
<dc:date>2003-06-01</dc:date>
<dc:identifier>10.1177/0091270003253350</dc:identifier>
<dc:title><![CDATA[Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron-Chelating Agent in Patients with Transfusion-Dependent Iron Overload Due to {beta}-Thalassemia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/37/1_suppl/40S?rss=1&amp;ssource=mfc">
<title><![CDATA[Use of Probe Drugs as Predictors of Drug Metabolism in Humans]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/37/1_suppl/40S?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Kari T. Kivisto, Heyo K. Kroemer<br />Jan  1, 1997; 37:40-48<br />Journal Article]]></description>
<dc:creator>Kari T. Kivisto, Heyo K. Kroemer</dc:creator>
<dc:date>1997-01-01</dc:date>
<dc:identifier>10.1177/009127009703700121</dc:identifier>
<dc:title><![CDATA[Use of Probe Drugs as Predictors of Drug Metabolism in Humans]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/34/11/1043?rss=1&amp;ssource=mfc">
<title><![CDATA[Pediatric medication errors: predicting and preventing tenfold disasters]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/34/11/1043?rss=1&amp;ssource=mfc</link>
<description><![CDATA[G Koren, RH Haslam<br />Nov  1, 1994; 34:1043-1045<br />Articles]]></description>
<dc:creator>G Koren, RH Haslam</dc:creator>
<dc:date>1994-11-01</dc:date>
<dc:title><![CDATA[Pediatric medication errors: predicting and preventing tenfold disasters]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

</rdf:RDF>